SS18
Basic information
Region (hg38): 18:26016253-26091217
Previous symbols: [ "SSXT" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SS18 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 1 | 0 |
Variants in SS18
This is a list of pathogenic ClinVar variants found in the SS18 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-26032455-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
18-26032532-C-G | not specified | Uncertain significance (Jan 10, 2022) | ||
18-26035031-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
18-26035050-G-A | Uncertain significance (Feb 02, 2021) | |||
18-26035879-C-T | not specified | Uncertain significance (Jun 04, 2024) | ||
18-26038558-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
18-26038588-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
18-26038599-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
18-26038626-T-C | not specified | Uncertain significance (May 24, 2024) | ||
18-26039368-C-T | not specified | Uncertain significance (Apr 12, 2023) | ||
18-26039370-T-C | not specified | Uncertain significance (Jul 13, 2022) | ||
18-26039415-T-C | not specified | Uncertain significance (Apr 11, 2023) | ||
18-26039451-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
18-26052637-C-A | not specified | Likely benign (Jun 09, 2022) | ||
18-26052643-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
18-26052672-T-C | not specified | Uncertain significance (May 02, 2024) | ||
18-26057649-T-G | not specified | Uncertain significance (Mar 30, 2024) | ||
18-26057736-T-A | not specified | Uncertain significance (Apr 08, 2022) | ||
18-26087561-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
18-26090514-G-A | not specified | Uncertain significance (Aug 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SS18 | protein_coding | protein_coding | ENST00000415083 | 11 | 74604 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.746 | 0.254 | 125739 | 0 | 9 | 125748 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.06 | 191 | 237 | 0.807 | 0.0000110 | 2768 |
Missense in Polyphen | 39 | 58.484 | 0.66685 | 683 | ||
Synonymous | 1.20 | 61 | 74.2 | 0.822 | 0.00000395 | 699 |
Loss of Function | 4.15 | 6 | 30.9 | 0.194 | 0.00000133 | 320 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000347 | 0.0000347 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000286 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000349 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Appears to function synergistically with RBM14 as a transcriptional coactivator. Isoform 1 and isoform 2 function in nuclear receptor coactivation. Isoform 1 and isoform 2 function in general transcriptional coactivation. Component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:29374058). {ECO:0000269|PubMed:15919756, ECO:0000269|PubMed:29374058}.;
- Pathway
- Transcriptional misregulation in cancer - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 45.13
Haploinsufficiency Scores
- pHI
- 0.887
- hipred
- Y
- hipred_score
- 0.853
- ghis
- 0.653
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.550
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ss18
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;
Gene ontology
- Biological process
- microtubule cytoskeleton organization;cell morphogenesis;intracellular signal transduction;response to drug;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;ephrin receptor signaling pathway;neuronal stem cell population maintenance
- Cellular component
- nucleus;cytoplasmic microtubule;SWI/SNF complex;npBAF complex
- Molecular function
- protein binding;nuclear receptor transcription coactivator activity